Perfusion System Market Size (2024 - 2029)

The perfusion system market is anticipated to experience significant growth, driven by increasing demand for organ transplantation and a rise in cardiovascular and respiratory diseases. Despite a temporary decline during the pandemic due to postponed surgical procedures and reduced organ donations, the market has begun to recover as restrictions ease and surgeries resume. Government initiatives to promote organ donations and product launches by key players are further contributing to market expansion. However, the high cost of devices and transplantation procedures may pose challenges to market growth.

Market Size of Perfusion System Industry

Perfusion System Market Summary
Study Period 2021 - 2029
Base Year For Estimation 2023
CAGR 8.20 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration High

Major Players

Perfusion System Market Major Players

*Disclaimer: Major Players sorted in no particular order

Perfusion System Market Analysis

The Perfusion System Market is expected to register a CAGR of 8.2% over the forecast period.

The pandemic has impacted the studied market. In spite of the high prevalence of cardiovascular and respiratory diseases, the majority of cardiac surgical procedures were postponed or canceled, and the number of organ donations and transplants decreased significantly due to the pandemic outbreak. As a result, during the pandemic, the market witnessed a slight drop in perfusion system sales. For instance, as per the press release by XVIVO Perfusion AB in March 2021, due to the Covid-19 pandemic, XVIVO Perfusion witnessed a decrease in demand for transplant products in 2020. This has had a detrimental influence on XVIVO Perfusion system sales in the first quarter of 2020. The company also said that the sales fell around 15.0% less than the previous year during the first quarter. Thus, owing to the reduced demand for perfusion systems, the market witnessed a slight adverse impact during the pandemic. However, with the resumption of surgical procedures, organ transplantation procedures, declining cases of COVID-19, and ease of restrictions, the market has started to gain traction. It is expected to continue the upward trend over the forecast period.

The rising demand for organ transplantation, an increase in the prevalence of cardiovascular and respiratory diseases, and rising initiatives by the government and various organizations to promote organ donations are the major factors propelling the market growth. For instance, as per the data published by the Health Resources and Services Administration in March 2022, about 40,000 organ transplants were performed in the United States in 2021. In addition, 26,670 kidney transplants and 9,236 live transplants were performed in 2021 in the United States. The perfusion system is one of the essential requirements for organ preservation and transplantation; thus increasing number of organ transplants is anticipated to increase the demand for perfusion system. In addition, there is a rising prevalence of cardiovascular and respiratory diseases across the globe is also boosting the demand for organ transplantation, which in turn propelling the market growth. For instance, according to the WHO 2021 factsheet, asthma is a major NCD affecting both children and adults. Globally, asthma affected more than 262.0 million people in 2021 and caused more than 461,000 deaths.

Furthermore, as per the research study published by the European Respiratory Society (ERS) published in 2021, ERS estimated that there were 36,580,965 Europeans with COPD, and the number is projected to reach 49,453,852 people by the year 2050. Thus, owing to the rising demand for organ transplantation and an increase in the prevalence of respiratory diseases, the market is expected to witness high growth. Moreover, rising product launches by the key market players are also anticipated to boost market growth. For instance, in December 2021, OrganOx, a manufacturer of normothermic machine perfusion (NMP), received premarket clearance (PMA) from the U.S. FDA for its metra system. The OrganOx metra is a fully automated NMP system that is used to preserve and transport donor livers for transplantation. Thus, owing to product launches and rising organ transplantation procedures, considerable market growth is expected over the forecast period.

However, the high cost of the devices and organ transplantation may restrain the market growth over the forecast period.

Perfusion System Industry Segmentation

As per the scope of the report, perfusion systems are the devices used for the passing of fluid into the circulatory system, an organ, or body tissue. The perfusion systems can be used in the transportation and stabilization of organs. 

The Perfusion System Market is segmented by Technology (Normothermic Machine Perfusion, Hypothermic Machine Perfusion), Type of Organ (Heart, Lung, Kidney, Liver, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (USD million) for the above segments.

By Technology
Normothermic Machine Perfusion
Hypothermic Machine Perfusion
By Type of Organ
Heart
Lung
Kidney
Liver
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Perfusion System Market Size Summary

The perfusion system market is poised for significant growth, driven by the increasing demand for organ transplantation and the rising prevalence of cardiovascular and respiratory diseases. The market experienced a temporary setback during the pandemic due to postponed surgical procedures and a decrease in organ donations and transplants. However, as restrictions eased and surgical activities resumed, the market began to recover and is expected to continue its upward trajectory. Key factors contributing to market expansion include government initiatives to promote organ donations, advancements in medical technology, and the introduction of innovative products by major market players. The market's growth is further supported by the rising incidence of chronic kidney diseases, which necessitates kidney transplants, thereby boosting the demand for perfusion systems.

North America is anticipated to witness substantial growth in the perfusion system market, attributed to its advanced healthcare infrastructure and technological advancements. The region's increasing burden of cardiovascular and respiratory diseases further fuels the demand for these systems. The competitive landscape is characterized by a few major players, with ongoing product launches, strategic partnerships, and regulatory approvals enhancing market dynamics. Despite the high cost of devices and organ transplantation posing potential challenges, the market's growth trajectory remains robust, driven by the continuous need for organ preservation and transplantation solutions.

Explore More

Perfusion System Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rising Demand for Organ Transplantation

      2. 1.2.2 Increase in the Prevalence of Cardiovascular and Respiratory Diseases

      3. 1.2.3 Rising Initiatives by Government and Various Organizations to Promote Organ Donations

    3. 1.3 Market Restraints

      1. 1.3.1 High Cost of the Devices and Organ Transplantation

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD Million)

    1. 2.1 By Technology

      1. 2.1.1 Normothermic Machine Perfusion

      2. 2.1.2 Hypothermic Machine Perfusion

    2. 2.2 By Type of Organ

      1. 2.2.1 Heart

      2. 2.2.2 Lung

      3. 2.2.3 Kidney

      4. 2.2.4 Liver

      5. 2.2.5 Others

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Australia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia-Pacific

      4. 2.3.4 Middle East and Africa

        1. 2.3.4.1 GCC

        2. 2.3.4.2 South Africa

        3. 2.3.4.3 Rest of Middle East and Africa

      5. 2.3.5 South America

        1. 2.3.5.1 Brazil

        2. 2.3.5.2 Argentina

        3. 2.3.5.3 Rest of South America

Perfusion System Market Size FAQs

The Perfusion System Market is projected to register a CAGR of 8.20% during the forecast period (2024-2029)

Organ Assist B.V., Organ Recovery Systems, Inc, TransMedics, Inc., Waters Medical Systems LLC and Paragonix Technologies, Inc are the major companies operating in the Perfusion System Market.

Perfusion System Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)